These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12638358)

  • 1. [The debate in Italy and in Europe about the adoption of pneumococcal vaccine in children].
    Maida A
    Ann Ig; 2002; 14(6 Suppl 7):1-5. PubMed ID: 12638358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy].
    Principi N; Esposito S
    Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France].
    Black S; Shinefield H; Cohen R; Floret D; Gaudelus J; Olivier C; Reinert P
    Arch Pediatr; 2004 Jul; 11(7):843-53. PubMed ID: 15234383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis.
    Brandileone MC; de Andrade AL; Di Fabio JL; Guerra ML; Austrian R
    J Infect Dis; 2003 Apr; 187(8):1206-12. PubMed ID: 12695999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumococcal vaccination; arguments for informing parents about the options available].
    Beaujean DJ; Verweij MF; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):909-11. PubMed ID: 15884402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipneumococcal vaccine: up date and prospective].
    Caramia G; Pastorelli G
    Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal vaccines.
    Ho CF; Lin TY
    Chang Gung Med J; 2005 Nov; 28(11):765-72. PubMed ID: 16422182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [7-valent conjugate Pneumococcal vaccine and nasopharyngeal cavity].
    Piffer S
    Ann Ig; 2002; 14(6 Suppl 7):31-7. PubMed ID: 12638362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
    Heininger U
    Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Invasive pneumococcal infection can cause meningitis in children. Uncertainty about the mass protective effect of the vaccine from USA].
    Eriksson M; Bennet R; Fuhrmann D; Giske CG; Rylander M
    Lakartidningen; 2007 Jun 13-26; 104(24-25):1906, 1908-10. PubMed ID: 17674670
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevenar vaccination: review of the global data, 2006.
    Center KJ
    Vaccine; 2007 Apr; 25(16):3085-9. PubMed ID: 17287048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
    Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
    Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
    Giorgi-Rossi P; Merito M; Borgia P
    Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.